Awareness Survey on Implantable Contact Lenses (Phakic Posterior Chamber Lenses) for Men and Women in their 20s-40s with Vision of 0.1 or Less
NQ Score
56/100
Key facts
- Awareness Survey on Implantable Contact Lenses (Phakic Posterior Chamber Lenses) for Men and Women in their 20s-40s with Vision of 0.1 or Less
- At-Working Co., Ltd., the Japanese distributor for IPCL®, an implantable contact lens approved in April 2025, surveyed men and women aged 20-40. The survey found that over 72% were aware of implantable contact lenses, and nearly 72% were interested, particularly women in their 20s and 30s. Key motivations for interest were the inconvenience of glasses/contacts and monthly lens costs, while primary concerns were fear of surgery and safety.
- Date: Mon Mar 30 2026 05:11:12 GMT+0900 (Japan Standard Time)
Direct answer
At-Working Co., Ltd., the Japanese distributor for IPCL®, an implantable contact lens approved in April 2025, surveyed men and women aged 20-40. The survey found that over 72% were aware of implantable contact lenses, and nearly 72% were interested, particularly women in their 20s and 30s. Key motivations for interest were the inconvenience of glasses/contacts and monthly lens costs, while primary concerns were fear of surgery and safety.
- Citation
- Awareness Survey on Implantable Contact Lenses (Phakic Posterior Chamber Lenses) for Men and Women in their 20s-40s with Vision of 0.1 or Less (Mon Mar 30 2026 05:11:12 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Mon Mar 30 2026 05:11:12 GMT+0900 (Japan Standard Time)
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is an implantable contact lens (IPCL) and how does it work?
- A: An implantable contact lens (IPCL) is a treatment method where a small lens is inserted into the eye to correct myopia and astigmatism, using an acrylic polymer material similar to that used in intraocular lenses and contact lenses.
- Q: What are the key advantages of IPCL compared to LASIK?
- A: Unlike LASIK, IPCL does not involve shaving the cornea, making it a highly reversible treatment that allows for the future removal of the implanted lens.
- Q: When was IPCL approved and launched in Japan?
- A: IPCL received pharmaceutical approval from the Ministry of Health, Labour and Welfare in April 2025 and was launched in Japan in September of the same year.
- Q: What was the purpose of the awareness survey conducted by At-Working Co., Ltd.?
- A: The survey was conducted to clarify the awareness and understanding of implantable contact lenses among men and women in their 20s to 40s with vision of 0.1 or less, considering societal trends and growing interest in surgical vision correction.
- Q: What were the general findings regarding awareness and interest in implantable contact lenses from the survey?
- A: Over 70% of respondents were aware of implantable contact lenses as a treatment method, and approximately 70% expressed interest in it as a vision correction option.